PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34115706-0	2021	Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.	Fluorodeoxyglucose F18	21-28	CD19 molecule	Homo sapiens	98-102	
35198451-0	2022	Prognostic Value of Radiomic Features of 18F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells.	Fluorodeoxyglucose F18	41-48	CD19 molecule	Homo sapiens	102-106	
33174144-0	2021	18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma.	Fluorodeoxyglucose F18	0-7	CD19 molecule	Homo sapiens	48-52